Global Parenteral Drugs Market Research Report 2020
SKU ID : QYR-15115951 | Publishing Date : 22-Jan-2020 | No. of pages : 136
Detailed TOC of Global Parenteral Drugs Market Research Report 2020
Table of Contents1 Parenteral Drugs Market Overview
1.1 Product Overview and Scope of Parenteral Drugs
1.2 Parenteral Drugs Segment by Type
1.2.1 Global Parenteral Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 LVP Drug
1.2.3 SVP Drug
1.3 Parenteral Drugs Segment by Application
1.3.1 Parenteral Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Medical Centers
1.3.4 Others
1.4 Global Parenteral Drugs Market Size Estimates and Forecasts
1.4.1 Global Parenteral Drugs Revenue 2015-2026
1.4.2 Global Parenteral Drugs Sales 2015-2026
1.4.3 Parenteral Drugs Market Size by Region: 2020 Versus 2026
2 Global Parenteral Drugs Market Competition by Manufacturers
2.1 Global Parenteral Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Parenteral Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Parenteral Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Parenteral Drugs Manufacturing Sites, Area Served, Product Type
2.5 Parenteral Drugs Market Competitive Situation and Trends
2.5.1 Parenteral Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Parenteral Drugs Players (Opinion Leaders)
3 Parenteral Drugs Retrospective Market Scenario by Region
3.1 Global Parenteral Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Parenteral Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Parenteral Drugs Market Facts & Figures by Country
3.3.1 North America Parenteral Drugs Sales by Country
3.3.2 North America Parenteral Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Parenteral Drugs Market Facts & Figures by Country
3.4.1 Europe Parenteral Drugs Sales by Country
3.4.2 Europe Parenteral Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Parenteral Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Parenteral Drugs Sales by Region
3.5.2 Asia Pacific Parenteral Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Parenteral Drugs Market Facts & Figures by Country
3.6.1 Latin America Parenteral Drugs Sales by Country
3.6.2 Latin America Parenteral Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Parenteral Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Parenteral Drugs Sales by Country
3.7.2 Middle East and Africa Parenteral Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Parenteral Drugs Historic Market Analysis by Type
4.1 Global Parenteral Drugs Sales Market Share by Type (2015-2020)
4.2 Global Parenteral Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Parenteral Drugs Price Market Share by Type (2015-2020)
4.4 Global Parenteral Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Parenteral Drugs Historic Market Analysis by Application
5.1 Global Parenteral Drugs Sales Market Share by Application (2015-2020)
5.2 Global Parenteral Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Parenteral Drugs Price by Application (2015-2020)
6 Company Profiles and Key Figures in Parenteral Drugs Business
6.1 Ostuka Pharmaceutical
6.1.1 Corporation Information
6.1.2 Ostuka Pharmaceutical Description, Business Overview and Total Revenue
6.1.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Ostuka Pharmaceutical Products Offered
6.1.5 Ostuka Pharmaceutical Recent Development
6.2 Teva Pharmaceutical Industries
6.2.1 Teva Pharmaceutical Industries Parenteral Drugs Production Sites and Area Served
6.2.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue
6.2.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Teva Pharmaceutical Industries Products Offered
6.2.5 Teva Pharmaceutical Industries Recent Development
6.3 Kelun Pharma
6.3.1 Kelun Pharma Parenteral Drugs Production Sites and Area Served
6.3.2 Kelun Pharma Description, Business Overview and Total Revenue
6.3.3 Kelun Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Kelun Pharma Products Offered
6.3.5 Kelun Pharma Recent Development
6.4 Cook Pharmica
6.4.1 Cook Pharmica Parenteral Drugs Production Sites and Area Served
6.4.2 Cook Pharmica Description, Business Overview and Total Revenue
6.4.3 Cook Pharmica Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Cook Pharmica Products Offered
6.4.5 Cook Pharmica Recent Development
6.5 Patheon
6.5.1 Patheon Parenteral Drugs Production Sites and Area Served
6.5.2 Patheon Description, Business Overview and Total Revenue
6.5.3 Patheon Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Patheon Products Offered
6.5.5 Patheon Recent Development
6.6 BAG Healthcare
6.6.1 BAG Healthcare Parenteral Drugs Production Sites and Area Served
6.6.2 BAG Healthcare Description, Business Overview and Total Revenue
6.6.3 BAG Healthcare Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 BAG Healthcare Products Offered
6.6.5 BAG Healthcare Recent Development
6.7 Beximco Pharma
6.6.1 Beximco Pharma Parenteral Drugs Production Sites and Area Served
6.6.2 Beximco Pharma Description, Business Overview and Total Revenue
6.6.3 Beximco Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Beximco Pharma Products Offered
6.7.5 Beximco Pharma Recent Development
6.8 Baxter Healthcare Corporation
6.8.1 Baxter Healthcare Corporation Parenteral Drugs Production Sites and Area Served
6.8.2 Baxter Healthcare Corporation Description, Business Overview and Total Revenue
6.8.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Baxter Healthcare Corporation Products Offered
6.8.5 Baxter Healthcare Corporation Recent Development
6.9 B. Braun
6.9.1 B. Braun Parenteral Drugs Production Sites and Area Served
6.9.2 B. Braun Description, Business Overview and Total Revenue
6.9.3 B. Braun Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 B. Braun Products Offered
6.9.5 B. Braun Recent Development
6.10 Fresenius
6.10.1 Fresenius Parenteral Drugs Production Sites and Area Served
6.10.2 Fresenius Description, Business Overview and Total Revenue
6.10.3 Fresenius Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Fresenius Products Offered
6.10.5 Fresenius Recent Development
6.11 Albert David
6.11.1 Albert David Parenteral Drugs Production Sites and Area Served
6.11.2 Albert David Parenteral Drugs Description, Business Overview and Total Revenue
6.11.3 Albert David Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Albert David Products Offered
6.11.5 Albert David Recent Development
6.12 BML Parenteral Drugs
6.12.1 BML Parenteral Drugs Parenteral Drugs Production Sites and Area Served
6.12.2 BML Parenteral Drugs Parenteral Drugs Description, Business Overview and Total Revenue
6.12.3 BML Parenteral Drugs Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.12.4 BML Parenteral Drugs Products Offered
6.12.5 BML Parenteral Drugs Recent Development
6.13 Pfizer (Hospira)
6.13.1 Pfizer (Hospira) Parenteral Drugs Production Sites and Area Served
6.13.2 Pfizer (Hospira) Parenteral Drugs Description, Business Overview and Total Revenue
6.13.3 Pfizer (Hospira) Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Pfizer (Hospira) Products Offered
6.13.5 Pfizer (Hospira) Recent Development
6.14 Pisa
6.14.1 Pisa Parenteral Drugs Production Sites and Area Served
6.14.2 Pisa Parenteral Drugs Description, Business Overview and Total Revenue
6.14.3 Pisa Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Pisa Products Offered
6.14.5 Pisa Recent Development
6.15 Ozon Pharmaceuticals Ltd
6.15.1 Ozon Pharmaceuticals Ltd Parenteral Drugs Production Sites and Area Served
6.15.2 Ozon Pharmaceuticals Ltd Parenteral Drugs Description, Business Overview and Total Revenue
6.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Ozon Pharmaceuticals Ltd Products Offered
6.15.5 Ozon Pharmaceuticals Ltd Recent Development
6.16 Aspen Holdings
6.16.1 Aspen Holdings Parenteral Drugs Production Sites and Area Served
6.16.2 Aspen Holdings Parenteral Drugs Description, Business Overview and Total Revenue
6.16.3 Aspen Holdings Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Aspen Holdings Products Offered
6.16.5 Aspen Holdings Recent Development
6.17 PSI Ltd
6.17.1 PSI Ltd Parenteral Drugs Production Sites and Area Served
6.17.2 PSI Ltd Parenteral Drugs Description, Business Overview and Total Revenue
6.17.3 PSI Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.17.4 PSI Ltd Products Offered
6.17.5 PSI Ltd Recent Development
6.18 Wintac Limited
6.18.1 Wintac Limited Parenteral Drugs Production Sites and Area Served
6.18.2 Wintac Limited Parenteral Drugs Description, Business Overview and Total Revenue
6.18.3 Wintac Limited Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Wintac Limited Products Offered
6.18.5 Wintac Limited Recent Development
6.19 AXA Parenterals Ltd
6.19.1 AXA Parenterals Ltd Parenteral Drugs Production Sites and Area Served
6.19.2 AXA Parenterals Ltd Parenteral Drugs Description, Business Overview and Total Revenue
6.19.3 AXA Parenterals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.19.4 AXA Parenterals Ltd Products Offered
6.19.5 AXA Parenterals Ltd Recent Development
6.20 Acebright
6.20.1 Acebright Parenteral Drugs Production Sites and Area Served
6.20.2 Acebright Parenteral Drugs Description, Business Overview and Total Revenue
6.20.3 Acebright Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.20.4 Acebright Products Offered
6.20.5 Acebright Recent Development
6.21 Southwest Pharmaceutical
6.21.1 Southwest Pharmaceutical Parenteral Drugs Production Sites and Area Served
6.21.2 Southwest Pharmaceutical Parenteral Drugs Description, Business Overview and Total Revenue
6.21.3 Southwest Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.21.4 Southwest Pharmaceutical Products Offered
6.21.5 Southwest Pharmaceutical Recent Development
6.22 Abbott
6.22.1 Abbott Parenteral Drugs Production Sites and Area Served
6.22.2 Abbott Parenteral Drugs Description, Business Overview and Total Revenue
6.22.3 Abbott Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
6.22.4 Abbott Products Offered
6.22.5 Abbott Recent Development
7 Parenteral Drugs Manufacturing Cost Analysis
7.1 Parenteral Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Parenteral Drugs
7.4 Parenteral Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Parenteral Drugs Distributors List
8.3 Parenteral Drugs Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Parenteral Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Parenteral Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Parenteral Drugs by Type (2021-2026)
10.2 Parenteral Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Parenteral Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Parenteral Drugs by Application (2021-2026)
10.3 Parenteral Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Parenteral Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Parenteral Drugs by Region (2021-2026)
10.4 North America Parenteral Drugs Estimates and Projections (2021-2026)
10.5 Europe Parenteral Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Parenteral Drugs Estimates and Projections (2021-2026)
10.7 Latin America Parenteral Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Parenteral Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Parenteral Drugs Market Research Report 2020
List of TablesTable 1. Global Parenteral Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Parenteral Drugs Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Parenteral Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Parenteral Drugs Manufacturers Covered in This Study
Table 5. Global Parenteral Drugs Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Parenteral Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Parenteral Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Parenteral Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Parenteral Drugs Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Parenteral Drugs Sales Sites and Area Served
Table 11. Manufacturers Parenteral Drugs Product Types
Table 12. Global Parenteral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Parenteral Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parenteral Drugs as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Parenteral Drugs Players
Table 16. Global Parenteral Drugs Sales (K Units) by Region (2015-2020)
Table 17. Global Parenteral Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Parenteral Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Parenteral Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Parenteral Drugs Sales by Country (2015-2020) (K Units)
Table 21. North America Parenteral Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Parenteral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Parenteral Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Parenteral Drugs Sales by Country (2015-2020) (K Units)
Table 25. Europe Parenteral Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Parenteral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Parenteral Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Parenteral Drugs Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Parenteral Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Parenteral Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Parenteral Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Parenteral Drugs Sales by Country (2015-2020) (K Units)
Table 33. Latin America Parenteral Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Parenteral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Parenteral Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Parenteral Drugs Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Parenteral Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Parenteral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Parenteral Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Parenteral Drugs Sales (K Units) by Type (2015-2020)
Table 41. Global Parenteral Drugs Sales Share by Type (2015-2020)
Table 42. Global Parenteral Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Parenteral Drugs Revenue Share by Type (2015-2020)
Table 44. Global Parenteral Drugs Price (USD/Unit) by Type (2015-2020)
Table 45. Global Parenteral Drugs Sales (K Units) by Application (2015-2020)
Table 46. Global Parenteral Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Parenteral Drugs Sales Growth Rate by Application (2015-2020)
Table 48. Ostuka Pharmaceutical Parenteral Drugs Corporation Information
Table 49. Ostuka Pharmaceutical Description and Business Overview
Table 50. Ostuka Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Ostuka Pharmaceutical Main Product
Table 52. Ostuka Pharmaceutical Recent Development
Table 53. Teva Pharmaceutical Industries Parenteral Drugs Corporation Information
Table 54. Teva Pharmaceutical Industries Corporation Information
Table 55. Teva Pharmaceutical Industries Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Teva Pharmaceutical Industries Main Product
Table 57. Teva Pharmaceutical Industries Recent Development
Table 58. Kelun Pharma Parenteral Drugs Corporation Information
Table 59. Kelun Pharma Corporation Information
Table 60. Kelun Pharma Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Kelun Pharma Main Product
Table 62. Kelun Pharma Recent Development
Table 63. Cook Pharmica Parenteral Drugs Corporation Information
Table 64. Cook Pharmica Corporation Information
Table 65. Cook Pharmica Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Cook Pharmica Main Product
Table 67. Cook Pharmica Recent Development
Table 68. Patheon Parenteral Drugs Corporation Information
Table 69. Patheon Corporation Information
Table 70. Patheon Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Patheon Main Product
Table 72. Patheon Recent Development
Table 73. BAG Healthcare Parenteral Drugs Corporation Information
Table 74. BAG Healthcare Corporation Information
Table 75. BAG Healthcare Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. BAG Healthcare Main Product
Table 77. BAG Healthcare Recent Development
Table 78. Beximco Pharma Parenteral Drugs Corporation Information
Table 79. Beximco Pharma Corporation Information
Table 80. Beximco Pharma Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Beximco Pharma Main Product
Table 82. Beximco Pharma Recent Development
Table 83. Baxter Healthcare Corporation Parenteral Drugs Corporation Information
Table 84. Baxter Healthcare Corporation Corporation Information
Table 85. Baxter Healthcare Corporation Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Baxter Healthcare Corporation Main Product
Table 87. Baxter Healthcare Corporation Recent Development
Table 88. B. Braun Parenteral Drugs Corporation Information
Table 89. B. Braun Corporation Information
Table 90. B. Braun Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. B. Braun Main Product
Table 92. B. Braun Recent Development
Table 93. Fresenius Parenteral Drugs Corporation Information
Table 94. Fresenius Corporation Information
Table 95. Fresenius Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Fresenius Main Product
Table 97. Fresenius Recent Development
Table 98. Albert David Parenteral Drugs Corporation Information
Table 99. Albert David Corporation Information
Table 100. Albert David Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Albert David Main Product
Table 102. Albert David Recent Development
Table 103. BML Parenteral Drugs Parenteral Drugs Corporation Information
Table 104. BML Parenteral Drugs Corporation Information
Table 105. BML Parenteral Drugs Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. BML Parenteral Drugs Main Product
Table 107. BML Parenteral Drugs Recent Development
Table 108. Pfizer (Hospira) Parenteral Drugs Corporation Information
Table 109. Pfizer (Hospira) Corporation Information
Table 110. Pfizer (Hospira) Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Pfizer (Hospira) Main Product
Table 112. Pfizer (Hospira) Recent Development
Table 113. Pisa Parenteral Drugs Corporation Information
Table 114. Pisa Corporation Information
Table 115. Pisa Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Pisa Main Product
Table 117. Pisa Recent Development
Table 118. Ozon Pharmaceuticals Ltd Parenteral Drugs Corporation Information
Table 119. Ozon Pharmaceuticals Ltd Corporation Information
Table 120. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Ozon Pharmaceuticals Ltd Main Product
Table 122. Ozon Pharmaceuticals Ltd Recent Development
Table 123. Aspen Holdings Parenteral Drugs Corporation Information
Table 124. Aspen Holdings Corporation Information
Table 125. Aspen Holdings Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Aspen Holdings Main Product
Table 127. Aspen Holdings Recent Development
Table 128. PSI Ltd Parenteral Drugs Corporation Information
Table 129. PSI Ltd Corporation Information
Table 130. PSI Ltd Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. PSI Ltd Main Product
Table 132. PSI Ltd Recent Development
Table 133. Wintac Limited Parenteral Drugs Corporation Information
Table 134. Wintac Limited Corporation Information
Table 135. Wintac Limited Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. Wintac Limited Main Product
Table 137. Wintac Limited Recent Development
Table 138. AXA Parenterals Ltd Parenteral Drugs Corporation Information
Table 139. AXA Parenterals Ltd Corporation Information
Table 140. AXA Parenterals Ltd Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 141. AXA Parenterals Ltd Main Product
Table 142. AXA Parenterals Ltd Recent Development
Table 143. Acebright Parenteral Drugs Corporation Information
Table 144. Acebright Corporation Information
Table 145. Acebright Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 146. Acebright Main Product
Table 147. Acebright Recent Development
Table 148. Southwest Pharmaceutical Parenteral Drugs Corporation Information
Table 149. Southwest Pharmaceutical Corporation Information
Table 150. Southwest Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 151. Southwest Pharmaceutical Main Product
Table 152. Southwest Pharmaceutical Recent Development
Table 153. Abbott Parenteral Drugs Corporation Information
Table 154. Abbott Corporation Information
Table 155. Abbott Parenteral Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 156. Abbott Main Product
Table 157. Abbott Recent Development
Table 158. Sales Base and Market Concentration Rate of Raw Material
Table 159. Key Suppliers of Raw Materials
Table 160. Parenteral Drugs Distributors List
Table 161. Parenteral Drugs Customers List
Table 162. Market Key Trends
Table 163. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 164. Key Challenges
Table 165. Global Parenteral Drugs Sales (K Units) Forecast by Type (2021-2026)
Table 166. Global Parenteral Drugs Sales Market Share Forecast by Type (2021-2026)
Table 167. Global Parenteral Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 168. Global Parenteral Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 169. Global Parenteral Drugs Sales (K Units) Forecast by Application (2021-2026)
Table 170. Global Parenteral Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 171. Global Parenteral Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 172. Global Parenteral Drugs Sales Market Share Forecast by Region (2021-2026)
Table 173. Global Parenteral Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 174. Global Parenteral Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Parenteral Drugs
Figure 2. Global Parenteral Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. LVP Drug Product Picture
Figure 4. SVP Drug Product Picture
Figure 5. Global Parenteral Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 6. Hospitals
Figure 7. Medical Centers
Figure 8. Others
Figure 9. Global Parenteral Drugs Market Size 2015-2026 (US$ Million)
Figure 10. Global Parenteral Drugs Sales Capacity (K Units) (2015-2026)
Figure 11. Global Parenteral Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Parenteral Drugs Sales Share by Manufacturers in 2020
Figure 13. Global Parenteral Drugs Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Parenteral Drugs Revenue in 2019
Figure 15. Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Parenteral Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Parenteral Drugs Sales Market Share by Region in 2019
Figure 18. Global Parenteral Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Parenteral Drugs Revenue Market Share by Region in 2019
Figure 20. North America Parenteral Drugs Sales Market Share by Country in 2019
Figure 21. North America Parenteral Drugs Revenue Market Share by Country in 2019
Figure 22. U.S. Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Parenteral Drugs Sales Market Share by Country in 2019
Figure 27. Europe Parenteral Drugs Revenue Market Share by Country in 2019
Figure 28. Germany Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Parenteral Drugs Sales Market Share by Region in 2019
Figure 39. Asia Pacific Parenteral Drugs Revenue Market Share by Region in 2019
Figure 40. China Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Parenteral Drugs Sales Market Share by Country in 2019
Figure 63. Latin America Parenteral Drugs Revenue Market Share by Country in 2019
Figure 64. Mexico Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Parenteral Drugs Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Parenteral Drugs Revenue Market Share by Country in 2019
Figure 72. Turkey Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Parenteral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. U.A.E Parenteral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Parenteral Drugs by Type (2015-2020)
Figure 79. Sales Market Share of Parenteral Drugs by Type in 2019
Figure 80. Revenue Share of Parenteral Drugs by Type (2015-2020)
Figure 81. Revenue Market Share of Parenteral Drugs by Type in 2019
Figure 82. Global Parenteral Drugs Sales Growth by Type (2015-2020) (K Units)
Figure 83. Global Parenteral Drugs Sales Market Share by Application (2015-2020)
Figure 84. Global Parenteral Drugs Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Parenteral Drugs by Application (2015-2020)
Figure 86. Global Revenue Share of Parenteral Drugs by Application in 2020
Figure 87. Ostuka Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Kelun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Cook Pharmica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Patheon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. BAG Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Beximco Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Baxter Healthcare Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. B. Braun Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Fresenius Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Albert David Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. BML Parenteral Drugs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Pfizer (Hospira) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Pisa Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Ozon Pharmaceuticals Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Aspen Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. PSI Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Wintac Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. AXA Parenterals Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Acebright Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Southwest Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Price Trend of Key Raw Materials
Figure 110. Manufacturing Cost Structure of Parenteral Drugs
Figure 111. Manufacturing Process Analysis of Parenteral Drugs
Figure 112. Parenteral Drugs Industrial Chain Analysis
Figure 113. Channels of Distribution
Figure 114. Distributors Profiles
Figure 115. Porter's Five Forces Analysis
Figure 116. North America Parenteral Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 117. North America Parenteral Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Europe Parenteral Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 119. Europe Parenteral Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 120. Latin America Parenteral Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 121. Latin America Parenteral Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 122. Middle East and Africa Parenteral Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 123. Middle East and Africa Parenteral Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 124. Asia Pacific Parenteral Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 125. Asia Pacific Parenteral Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
Keyplayers in Global Parenteral Drugs Market Research Report 2020
Ostuka PharmaceuticalTeva Pharmaceutical Industries
Kelun Pharma
Cook Pharmica
Patheon
BAG Healthcare
Beximco Pharma
Baxter Healthcare Corporation
B. Braun
Fresenius
Albert David
BML Parenteral Drugs
Pfizer (Hospira)
Pisa
Ozon Pharmaceuticals Ltd
Aspen Holdings
PSI Ltd
Wintac Limited
AXA Parenterals Ltd
Acebright
Southwest Pharmaceutical
Abbott